Press Releases Reneo Pharmaceuticals, Inc.

Equities

RPHM

US75974E1038

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-13 EDT			5-day change	1st Jan Change
1.59 ^USD	-12.15%		-8.09%	-0.62%

02:28pm	Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise	MT
05-07	Reneo Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shareholder Alert: Ademi LLP investigates whether Reneo Pharmaceuticals, Inc. has obtained a Fair Price in its Transaction with OnKure	12:03pm	PR
RPHM Alert: Monsey Firm of Wohl & Fruchter Investigating Proposed Merger of Reneo Pharmaceuticals With OnKure	10:29am	AQ
RPHM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Reneo Pharmaceuticals, Inc. Is Fair to Shareholders	08:58am	BU
Reneo Pharmaceuticals and OnKure Announce Proposed Merger	07:35am	GL
Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results	05-07	GL
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update	03-28	GL
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)	12-14	GL
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)	12-14	AQ
Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results	11-13	GL
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences	11-02	GL
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences	11-02	AQ
Women in Stem with Ashley Hall	23-10-31	AQ
Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings	23-10-25	GL
Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings	23-10-25	AQ
Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)	23-10-09	GL
Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)	23-10-09	AQ
Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit	23-10-06	GL
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences	23-08-29	GL
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences	23-08-29	AQ
Reneo Pharmaceuticals Reports Second Quarter 2023 Financial Results	23-08-10	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Reneo Pharmaceuticals, Inc.

Equities

RPHM

US75974E1038

Press Releases

Filters